|
|
Article: BrainStorm Cell Therapeutics' Adult Stem Cell Approach More Relevant Than Embryonic Stem Cell Therapies.
- Article from:
- Business Wire
- Article date:
- November 27, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BrainStorm Adult Stem Cell Treatment should not Pose the Risk of Teratomas (cancer) that Characterize Embryonic Stem Cell Therapies; Company's Adult Stem Cell Therapies Avoid Ethical, Religious and Medical Controversies and are Currently in Pre-Clinical Trials
NEW YORK & PETACH TIKVAH, Israel -- BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that based on studies conducted to date, the Company's adult stem cell therapies provide a safer approach at curing and treating neurodegenerative diseases than competitive therapies that rely on embryonic stem cells. In addition to ...